-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Wave Life Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q4 2024.
- Wave Life Sciences Ltd. Operating Income (Loss) for the quarter ending December 31, 2024 was $23M.
- Wave Life Sciences Ltd. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$110M, a 62.4% decline year-over-year.
- Wave Life Sciences Ltd. annual Operating Income (Loss) for 2024 was -$110M, a 62.4% decline from 2023.
- Wave Life Sciences Ltd. annual Operating Income (Loss) for 2023 was -$68M, a 58.2% increase from 2022.
- Wave Life Sciences Ltd. annual Operating Income (Loss) for 2022 was -$163M, a 28.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)